| 1. |
GENERAL EVALUATION |
| 1.1 |
How would you rate this Meeting? (1=Poor 10=Excellent) |
| |
1
2
3
4
5
6
7
8
9
10 |
| 1.2 |
Did this Meeting
meet your expectations? yes
no |
| 1.3 |
Did this program
prove useful to your work? |
| |
extremely
somewhat
very little
not at all |
| 1.4 |
Do you have any
suggestions for next year’s Meeting? |
| |
|
| 1.5 |
Overall comments |
| |
|
| |
|
|
2. |
PLENARY SESSIONS |
| 2.1 |
How would you rate the First Plenary Session,
“New Evidence on Evidence-Based Technology Assessment in the USA vs. Canada”?
(1=Poor 10=Excellent) |
| |
Didn't attend
1
2
3
4
5
6
7
8
9
10 |
| 2.2 |
How would you rate the Second Plenary Session
“Drug Safety and Risk-Benefit Decision-Making”?
(1=Poor 10=Excellent) |
| |
Didn't attend
1
2
3
4
5
6
7
8
9
10 |
| 2.3 |
How would you rate the Third Plenary Session
“Patient Reported Outcomes: Implementing Good Research Practices”?
(1=Poor 10=Excellent) |
| |
Didn't attend
1
2
3
4
5
6
7
8
9
10 |
| 2.4 |
Do you have any
suggestions for next year’s Plenary Sessions topics? |
| |
|
| 2.5 |
Comments on the
Plenary Sessions |
| |
|
| |
|
|
3. |
ISSUE PANELS |
| |
How would you rate the Issue Panels? (1=Poor
10=Excellent) |
| 3.1 |
IP1: COMPARATIVE EFFECTIVENESS RESEARCH: BREAKING THE METHODS MOLD |
| |
Didn't attend
1
2
3
4
5
6
7
8
9
10 |
| 3.2 |
IP2: IS NICE ALL THAT NASTY? COMPARISONS OF ACCESS TO CANCER THERAPY IN UK AND US HEALTH CARE |
| |
Didn't attend
1
2
3
4
5
6
7
8
9
10 |
| 3.3 |
IP3: ESTABLISHING KEY PRINCIPLES FOR HEALTH TECHNOLOGY ASSESSMENT |
| |
Didn't attend
1
2
3
4
5
6
7
8
9
10 |
| 3.4 |
IP4: NOW WHAT FOR GENOMICS? TURNING PROMISE INTO PRACTICE |
| |
Didn't attend
1
2
3
4
5
6
7
8
9
10 |
| 3.5 |
IP5: PATIENT-REPORTED OUTCOMES, HEALTH-STATE UTILITIES, OR STATED-PREFERENCES? SIMILARITIES, DIFFERENCES AND ROLES IN DEMONSTRATING PRODUCT VALUE |
| |
Didn't attend
1
2
3
4
5
6
7
8
9
10 |
| 3.6 |
IP6: ARE GOOD PRACTICE PRINCIPLES FOR OBSERVATIONAL COMPARATIVE EFFECTIVENESS RESEARCH NEEDED? |
| |
Didn't attend
1
2
3
4
5
6
7
8
9
10 |
| 3.7 |
IP7: WHAT DID THE MEDICARE REPLACEMENT DRUG DEMONSTRATION TEACH US ABOUT THE ROLE OF COST-EFFECTIVENESS ANALYSES IN PUBLIC POLICY? |
| |
Didn't attend
1
2
3
4
5
6
7
8
9
10 |
| 3.8 |
IP8: QUANTITATIVE APPROACHES TO REGULATORY RISK-BENEFIT ASSESSMENT FOR FDA DECISION-MAKING: WHAT WOULD WORK? |
| |
Didn't attend
1
2
3
4
5
6
7
8
9
10 |
| 3.9 |
IP9: PRACTICAL CONSIDERATIONS ON COVERAGE WITH EVIDENCE DEVELOPMENT: HOW WILL THE PIPER BE PAID? |
| |
Didn't attend
1
2
3
4
5
6
7
8
9
10 |
| 3.10 |
IP10: QALYS GONE WILD? |
| |
Didn't attend
1
2
3
4
5
6
7
8
9
10 |
| 3.11 |
Do you have any suggestions for future Issue
Panel topics? |
| |
|
| 3.12 |
Comments on the Issue Panels |
| |
|
| |
|
| 4. |
ISPOR FORUMS |
| |
How would you rate the Forums? (1=Poor 10=Excellent) |
| 4.1 |
ISPOR PRO - Changing Culture or Language of a Instrument TF Forum (Monday)
Multinational trials - What translations are required, what methodology should be used and what methodology supports pooling the data? |
| |
Didn't Attend
1
2
3
4
5
6
7
8
9
10 |
| 4.2 |
ISPOR Patient Registry SIG Forum (Monday)
Registry Design, Operations, Data & Taxonomy |
| |
Didn't Attend
1
2
3
4
5
6
7
8
9
10 |
| 4.3 |
ISPOR Retrospective Database SIG Forum (Monday)
What You Need to Know about the ISPOR Digest of International Databases |
| |
Didn't Attend
1
2
3
4
5
6
7
8
9
10 |
| 4.4 |
ISPOR HTA SIG Forum (Tuesday)
Navigating the Health Technology Assessment Process Around the World |
| |
Didn't Attend
1
2
3
4
5
6
7
8
9
10 |
| 4.5 |
ISPOR Fellowship Standards TF Forum (Tuesday)
Pharmacoeconomic and Outcomes Research Fellowship Standards |
| |
Didn't Attend
1
2
3
4
5
6
7
8
9
10 |
| 4.6 |
ISPOR Medication Compliance & Persistence SIG Forum (Tuesday)
Assessment, Determinants & Economics of Medication Compliance & Persistence |
| |
Didn't Attend
1
2
3
4
5
6
7
8
9
10 |
| 4.7 |
ISPOR Good Research Practices for Retrospective Database Analysis TF Forum (Tuesday)
Design and Analysis of Non-Randomized Studies of Treatment Effects using Secondary Databases |
| |
Didn't Attend
1
2
3
4
5
6
7
8
9
10 |
| 4.8 |
ISPOR Good Research Practices On Economic Data Transferability TF Forum (Tuesday)
Relaxing the Border Controls on Pharmacoeconomic Studies |
| |
Didn't Attend
1
2
3
4
5
6
7
8
9
10 |
| 4.9 |
ISPOR Quality Improvement in Cost-Effectiveness Research (QICER) TF Forum (Tuesday)
Issues and Challenges for Assessing and Improving Quality |
| |
Didn't Attend
1
2
3
4
5
6
7
8
9
10 |
| 4.10 |
ISPOR Student Network Educational Forum (Tuesday)
Overview of Decision Analysis and its Application |
| |
Didn't Attend
1
2
3
4
5
6
7
8
9
10 |
| 4.11 |
Do you have any suggestions for future Forum topics? |
| |
|
| 4.12 |
Comments on the Forums |
| |
|
| |
|
|
5. |
PODIUM PRESENTATIONS |
| 5.1 |
In general, how would you rate the Podium Presentations? (1=Poor 10=Excellent) |
| |
Didn't attend
1
2
3
4
5
6
7
8
9
10 |
| |
If attended: |
| 5.1.1 |
Were the speakers
knowledgeable on their topics? |
yes
no |
| 5.1.2 |
Were there
handouts/printed materials available? |
yes
no |
| 5.1.3 |
Were the visual
presentations clear and easy to read? |
yes
no |
| 5.1.4 |
Please list any
comments regarding Podium Presentations |
| |
|
| 5.2 |
*New* Health Care Decisions Using Outcomes Research Information Case Studies - Podiums
In particular, how would you rate the Case Study Podiums? (1=Poor 10=Excellent) |
| |
Didn't attend
1
2
3
4
5
6
7
8
9
10 |
| |
If attended: |
| 5.2.1 |
Were the speakers
knowledgeable on their topics? |
yes
no |
| 5.2.2 |
Were there
handouts/printed materials available? |
yes
no |
| 5.2.3 |
Were the visual
presentations clear and easy to read? |
yes
no |
| 5.2.4 |
Please list any
comments regarding Podium Presentations |
| |
|
| |
|
|
6. |
POSTER PRESENTATIONS |
| 6.1 |
In general, how
would you rate the Poster Presentations? (1=Poor 10=Excellent) |
| |
1
2
3
4
5
6
7
8
9
10 |
| 6.2 |
Were there
handouts/printed materials available? |
yes
no |
| 6.3 |
Were the visual
presentations clear and easy to read? |
yes
no |
| 6.4 |
Please list any comments
regarding Poster Presentations |
| |
|
| |
|
|
7. |
WORKSHOP PRESENTATIONS
|
| 7.1 |
In general, how would you rate the Workshop Presentations? (1=Poor 10=Excellent) |
| |
Didn't attend
1
2
3
4
5
6
7
8
9
10 |
| |
If attended: |
| 7.2 |
Were speakers knowledgeable on
their topics? |
yes
no |
| 7.3 |
Were there handouts/printed
materials available? |
yes
no |
| 7.4 |
Were the visual presentations
clear and easy to read? |
yes
no |
| 7.5 |
Did any workshops appear to be advertising the
presenter’s company’s services or products? |
yes
no |
|
If yes, which
workshops? |
| 7.6 |
Please list any comments
regarding Workshop Presentations: |
|
|
|
|
| 8. |
EXHIBITION |
| 8.1 |
How would you rate the
exhibits? (1=poor 5=excellent) |
| |
1
2
3
4
5 |
| 8.2 |
Were the exhibit hours long enough? (1=too short 5=too long) |
| |
1
2
3
4
5 |
| |
|
|
9. |
ISPOR Professional Recruitment Assistance
Program (PRAP) Center |
| 9.1 |
Was the PRAP area useful? (1=not useful at all 5=very useful) |
| |
Did not use
1
2
3
4
5 |
| |
|
| 10. |
MEETING MANAGEMENT |
| 10.1 |
Was the Meeting well run?
(1=poor 5=excellent) |
|
1
2
3
4
5 |
| 10.2 |
Was the printed program clear
and easy to follow? (1=poor 5=excellent) |
| |
1
2
3
4
5 |
| |
|
| 11. |
FUTURE ISPOR MEETINGS AND CONGRESSES |
| 11.1 |
Do you plan to attend the ISPOR 3rd Asia-Pacific Conference to be held 7-9 September 2008 in Seoul, South Korea? |
| |
yes
no
not sure |
| 11.2 |
Do you plan to attend the ISPOR 11th Annual European Congress to be held 8-11 November 2008 in Athens, Greece? |
| |
yes
no
not sure |
| 11.3 |
Do you
plan to attend the ISPOR 14th Annual International Meeting to be held May 16 - 20, 2009 in Orlando, Florida, USA? |
| |
yes
no
not sure |
| |
|
| 12. |
Participant Information |
| 12.1 |
Are you a: |
| |
Registrant
Contributed paper presenter
Media representative
Exhibitor
Other |
| 12.2 |
What type of organization do you represent? |
| |
|
| 12.3 |
How long have you been working in the field of pharmacoeconomics and outcomes
research? |
| |
less than 1 year
1-2 years
2-5 years
5-10 years
10-15 years
15-20 years
more than 20 years |
| 12.4 |
How many ISPOR Annual Meetings have you attended before this one? |
| |
none
1
2
3
4
5
6
7
8
9
10
11
12 |
| 12.5 |
How did you first hear of this Meeting? |
| |
ISPOR Connections
Conference Mailing
Colleague
Other ( please specify)
|
| 12.6 |
Do you have any comments or suggestions for the ISPOR 14th Annual International
Meeting? |
| |
|
